The Effect of Sildenafil Citrate (Viagra®) on Nasal Olfactory Mucosa of Adult Male Albino Rat: caspase-3 and inducible nitric oxide synthase protein expressions
Abstract
Like all human senses, the sense of olfaction (smell) plays an important role in person’s life. The sense of smell serves as a first warning signal, warning to the smoke of a fire, spoiled food, or the odor of a natural gas leak or dangerous fumes. Olfactory mucosa is a component of nervous system which regenerate throughout person's lifetime. Dysfunction of olfactory sensitivity may be a side effect of chronic use of high sildenafil doses. Sildenafil is oral drug effective for erectile dysfunction in men, and approximately 20% of patients complain about nasal congestion after sildenafil administration. Aim of this study was to evaluate effect of long-term sildenafil administration on rat olfactory mucosa. Forty-five male albino rats were divided into three equal groups, group I kept as control. Rats in groups II and III received sildenafil citrate orally at doses of 50 mg/kg and 100 mg/kg, respectively for three months. At the end, olfactory mucosa removed, fixed in proper fixations for histopathology, immunohistochemistry, and SEM. Results revealed that rats treated with high dose of sildenafil revealed loss of smell as well as alteration of histological pictures, immunohistochemical staining of apoptotic markers and SEM of olfactory mucosa while the rats in group II revealed normal sense of olfaction and normal histology of olfactory mucosa. In conclusion, chronic use of 100 mg sildenafil citrate led to olfactory dysfunction through stimulation of iNOS and Caspase 3…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.